Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients

Completed

Conditions studied: Lung Cancer

In brief

The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.

Key facts

Study ID

NCT01466946

Run by

Memorial Sloan Kettering Cancer Center

People needed

25

Starts

2011-11-01

Expected to finish

2016-02-01

Last updated by the study team

2016-02-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC, including stages of disease I-IV
• 18 years of age or older
• Fluent in English or Spanish
• Patients must reside in the U.S

You may not qualify if…

• Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g., Philippines-born individuals)

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.